Neuroinflammation

studied byStudied by 0 people
0.0(0)
learn
LearnA personalized and smart learning plan
exam
Practice TestTake a test on your terms and definitions
spaced repetition
Spaced RepetitionScientifically backed study method
heart puzzle
Matching GameHow quick can you match all your cards?
flashcards
FlashcardsStudy terms and definitions

1 / 10

encourage image

There's no tags or description

Looks like no one added any tags here yet for you.

11 Terms

1

Which MS neuromodulatory medication is cardiotoxic?

Mitoxantrone

New cards
2

Which MS meds can be taken pos?

Teriflunomide, dimethyl fumarate, Ozanimod, fingolimod, siponimod (SIP), cladribine

New cards
3

Cladribine dose and what should you look for before starting?

3.5mg/kg over 2 years, 2 cycles of 1.75/year. Look for lymphocyte count - it should be >= 800 cells/mm before the second cycle and normal before the first course and monitor for infections (>10%).

New cards
4

Pathology differences in MS, NMO, MOG

MS: microglial rims, well-defined

NMO: perivenous inflammation, necrosis of oligodendrocytes, granulocytic cell infiltrates

MOG: meningeal inflammation in association with topographically related cortical demyelination

New cards
5

How many years are roughly required for EDSS 6 in RRMS vs in PPMS?

EDSS 6 is typically reached in about 15 years in RRMS, while in PPMS it can occur in 8 years.

New cards
6

Which DMTs can be used in paediatric MS?

fingolimod, teriflunomide, and dimethyl fumarate, possibly also interferon beta, glatiramer acetate

New cards
7

FOr which DMT should you check CYP2C9 status?

Ozanimod

New cards
8

What receptors target the different S1P DMTs?

Fingolimod: 1, 3, 4, 5

Siponimod: 1, 5

Ozanimod: 1, 5

Ponesimod: 1

New cards
9

Treatment options for AQP4 NMO

high-dose corticosteroids, plasma exchange, or IVIg

IL-6 receptor inhibitors (eg, tocilizumab) and cyclophosphamide

Eculizumab

New cards
10

Relapse prevention in AQP4-NMOSD

rituximab (anti-CD20), inebilizumab (anti-CD19), satralizumab and tocilizumab (anti-IL-6), and eculizumab and ravulizumab (anti-C5)

New cards
11
New cards
robot